{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T19:17:13Z","timestamp":1767640633411,"version":"3.48.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Cystic fibrosis (CF) is a multi-system disease caused by CFTR dysfunction. Genetic defects in the CFTR protein cause impaired chloride and bicarbonate secretion on the apical surface of epithelial cells throughout the body. Classically, the diagnosis of CF is established based on a clinical presentation suggestive of CF along with two elevated sweat chloride test results (\u2265\u200960 mmol\/L) or the presence of two pathogenic disease-causing\n                      <jats:italic>CFTR<\/jats:italic>\n                      variants. This study aimed to characterize and compare a subset of patients who present with a CF-like phenotype and elevated sweat chlorides with (\u2018CF control\u2019) vs. without (\u2018cases\u2019) disease-causing\n                      <jats:italic>CFTR<\/jats:italic>\n                      variants.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Cases were found to have more upper respiratory tract symptoms (sinusitis, nasal polyps, and recurrent sinus infections) compared to CF controls. Furthermore, cases experienced fewer pulmonary exacerbations per year, had less evidence of bronchiectasis, peribronchial thickening, and mucus plugging on CT scan imaging, and fewer organisms identified on sputum microbiology. Compared to CF controls, cases were also noted to have fewer gastrointestinal and genitourinary manifestations of CF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The clinical features of patients with elevated sweat chlorides in the absence of\n                      <jats:italic>CFTR<\/jats:italic>\n                      variants are distinct from patients with\n                      <jats:italic>CFTR<\/jats:italic>\n                      variants and comparable sweat chlorides. Further investigation into this subset of patients may elucidate alternative causes for this CF-like phenotype.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-04145-w","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T05:27:42Z","timestamp":1764394062000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterizing individuals with elevated sweat chloride results in the absence of CFTR variants"],"prefix":"10.1186","volume":"21","author":[{"given":"Ishmam","family":"Bhuiyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank Y.","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Franciosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley S.","family":"Quon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"issue":"19","key":"4145_CR1","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1056\/NEJMra043184","volume":"352","author":"SM Rowe","year":"2005","unstructured":"Rowe SM, Miller S, Sorscher EJ. Cystic fibrosis. N Engl J Med. 2005;352(19):1992\u20132001.","journal-title":"N Engl J Med"},{"issue":"1","key":"4145_CR2","doi-asserted-by":"publisher","first-page":"a009498","DOI":"10.1101\/cshperspect.a009498","volume":"3","author":"TC Hwang","year":"2013","unstructured":"Hwang TC, Kirk KL. The CFTR ion channel: Gating, Regulation, and anion permeation. Cold Spring Harb Perspect Med. 2013;3(1):a009498.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"3","key":"4145_CR3","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.chest.2018.10.006","volume":"155","author":"TG Liou","year":"2019","unstructured":"Liou TG. The clinical biology of cystic fibrosis transmembrane regulator protein. Chest. 2019;155(3):605\u201316.","journal-title":"Chest"},{"issue":"5899","key":"4145_CR4","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/301421a0","volume":"301","author":"PM Quinton","year":"1983","unstructured":"Quinton PM. Chloride impermeability in cystic fibrosis. Nature. 1983;301(5899):421\u20132.","journal-title":"Nature"},{"issue":"8","key":"4145_CR5","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1164\/rccm.200304-505SO","volume":"168","author":"RL Gibson","year":"2003","unstructured":"Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med. 2003;168(8):918\u201351.","journal-title":"Am J Respir Crit Care Med"},{"key":"4145_CR6","unstructured":"Yu E, Sharma S. Cystic Fibrosis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 [cited 2022 May 23]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK493206\/"},{"issue":"3","key":"4145_CR7","first-page":"136","volume":"9","author":"N Kobelska-Dubiel","year":"2014","unstructured":"Kobelska-Dubiel N, Klincewicz B, Cichy W. Liver disease in cystic fibrosis. Przegla\u031cd Gastroenterol. 2014;9(3):136\u201341.","journal-title":"Przegla\u031cd Gastroenterol"},{"key":"4145_CR8","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1016\/j.jcf.2017.07.006","volume":"16","author":"DN Assis","year":"2017","unstructured":"Assis DN, Debray D. Gallbladder and bile duct disease in cystic fibrosis. J Cyst Fibros. 2017;16:S62\u20139.","journal-title":"J Cyst Fibros"},{"issue":"4","key":"4145_CR9","first-page":"1075","volume":"151","author":"TZ Khan","year":"1995","unstructured":"Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med. 1995;151(4):1075\u201382.","journal-title":"Am J Respir Crit Care Med"},{"key":"4145_CR10","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2147\/COPD.S6133","volume":"4","author":"PT King","year":"2009","unstructured":"King PT. The pathophysiology of bronchiectasis. Int J Chron Obstruct Pulmon Dis. 2009;4:411\u20139.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"4145_CR11","doi-asserted-by":"crossref","unstructured":"Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Derichs N et al. Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation. J Pediatr. 2017;181:S4-S15.e1.","DOI":"10.1016\/j.jpeds.2016.09.064"},{"issue":"4","key":"4145_CR12","doi-asserted-by":"publisher","first-page":"00227","DOI":"10.1183\/23120541.00227-2022","volume":"8","author":"AN Franciosi","year":"2022","unstructured":"Franciosi AN, Tanzler A, Goodwin J, Wilcox PG, Solomon GM, Faro A, et al. Diagnostic agreement among experts assessing adults presenting with possible cystic fibrosis: need for improvement and implications for patient care. ERJ Open Res. 2022;8(4):00227\u20132022.","journal-title":"ERJ Open Res"},{"issue":"6","key":"4145_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1056\/NEJMoa011899","volume":"347","author":"JD Groman","year":"2002","unstructured":"Groman JD, Meyer ME, Wilmott RW, Zeitlin PL, Cutting GR. Variant cystic fibrosis phenotypes in the absence of CFTR mutations. N Engl J Med. 2002;347(6):401\u20137.","journal-title":"N Engl J Med"},{"issue":"5","key":"4145_CR14","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1007\/s004390050744","volume":"102","author":"F Mekus","year":"1998","unstructured":"Mekus F, Ballmann M, Bronsveld I, D\u00f6rk T, Bijman J, T\u00fcmmler B, et al. Cystic-fibrosis-like disease unrelated to the cystic fibrosis transmembrane conductance regulator. Hum Genet. 1998;102(5):582\u20136.","journal-title":"Hum Genet"},{"issue":"4","key":"4145_CR15","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3390\/genes11040401","volume":"11","author":"PM Farrell","year":"2020","unstructured":"Farrell PM, Rock MJ, Baker MW. The impact of the CFTR gene discovery on cystic fibrosis Diagnosis, Counseling, and preventive therapy. Genes. 2020;11(4):401.","journal-title":"Genes"},{"issue":"1","key":"4145_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1465-9921-9-46","volume":"9","author":"I Fajac","year":"2008","unstructured":"Fajac I, Viel M, Sublemontier S, Hubert D, Bienvenu T. Could a defective epithelial sodium channel lead to bronchiectasis. Respir Res. 2008;9(1):46.","journal-title":"Respir Res"},{"issue":"10","key":"4145_CR17","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1093\/hmg\/ddw065","volume":"25","author":"M Lee","year":"2016","unstructured":"Lee M, Vecchio-Pag\u00e1n B, Sharma N, Waheed A, Li X, Raraigh KS, et al. Loss of carbonic anhydrase XII function in individuals with elevated sweat chloride concentration and pulmonary airway disease. Hum Mol Genet. 2016;25(10):1923\u201333.","journal-title":"Hum Mol Genet"},{"issue":"22","key":"4145_CR18","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1093\/hmg\/ddi374","volume":"14","author":"MB Sheridan","year":"2005","unstructured":"Sheridan MB, Fong P, Groman JD, Conrad C, Flume P, Diaz R, et al. Mutations in the beta-subunit of the epithelial Na\u2009+\u2009channel in patients with a cystic fibrosis-like syndrome. Hum Mol Genet. 2005;14(22):3493\u20138.","journal-title":"Hum Mol Genet"},{"key":"4145_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.gene.2017.04.027","volume":"623","author":"A Waheed","year":"2017","unstructured":"Waheed A, Sly WS. Carbonic anhydrase XII functions in health and disease. Gene. 2017;623:33\u201340.","journal-title":"Gene"},{"key":"4145_CR20","unstructured":"CFTR2 Clinical and Fucntional Translation of CFTR [Internet]. Available from: https:\/\/cftr2.org\/welcome"},{"issue":"1","key":"4145_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/01.rti.0000203937.82276.ce","volume":"21","author":"AS Brody","year":"2006","unstructured":"Brody AS, Kosorok MR, Li Z, Broderick LS, Foster JL, Laxova A, et al. Reproducibility of a scoring system for computed tomography scanning in cystic fibrosis. J Thorac Imaging. 2006;21(1):14\u201321.","journal-title":"J Thorac Imaging"},{"issue":"4","key":"4145_CR22","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1513\/pats.200611-175HT","volume":"4","author":"PA de Jong","year":"2007","unstructured":"de Jong PA, Tiddens HAWM. Cystic fibrosis specific computed tomography scoring. Proc Am Thorac Soc. 2007;4(4):338\u201342.","journal-title":"Proc Am Thorac Soc"},{"issue":"6","key":"4145_CR23","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jcf.2022.09.011","volume":"21","author":"C Castellani","year":"2022","unstructured":"Castellani C, De Boeck K, De Wachter E, Sermet-Gaudelus I, Simmonds NJ, Southern KW, et al. ECFS standards of care on CFTR-related disorders: updated diagnostic criteria. J Cyst Fibros Off J Eur Cyst Fibros Soc. 2022;21(6):908\u201321.","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"key":"4145_CR24","doi-asserted-by":"crossref","unstructured":"Derichs N, Sanz J, Kanel TV, Stolpe C, Zapf A, T\u00fcmmler B et al. Intestinal current measurement for diagnostic classification of patients with questionable cystic fibrosis: validation and reference data. Thorax. 2010;65(7):594\u20139.","DOI":"10.1136\/thx.2009.125088"},{"key":"4145_CR25","doi-asserted-by":"crossref","unstructured":"Wilschanski M, Famini H, Strauss-Liviatan N, Rivlin J, Blau H, Bibi H, et al. Nasal potential difference measurements in patients with atypical cystic fibrosis. Eur Respir J. 2001;17(6):1208\u201315.","DOI":"10.1183\/09031936.01.00092501"},{"key":"4145_CR26","doi-asserted-by":"crossref","unstructured":"Muilwijk D, de Poel E, van Mourik P, Suen SWF, Vonk AM, Brunsveld JE et al. Forskolin-induced organoid swelling is associated with long-term cystic fibrosis disease progression. Eur Respir J [Internet]. 2022 [cited 2025 Sept 20];60(2). Available from: https:\/\/publications.ersnet.org\/content\/erj\/60\/2\/2100508","DOI":"10.1183\/13993003.00508-2021"},{"issue":"3","key":"4145_CR27","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.3390\/ijms23031437","volume":"23","author":"AS Ramalho","year":"2022","unstructured":"Ramalho AS, Boon M, Proesmans M, Vermeulen F, Carlon MS, De Boeck K. Assays of CFTR function in Vitro, ex vivo and in vivo. Int J Mol Sci. 2022;23(3):1437.","journal-title":"Int J Mol Sci"},{"key":"4145_CR28","doi-asserted-by":"crossref","unstructured":"Addissouky TA, Sayed IETE, Ali MMA, Wang Y. Emerging biomarkers for precision diagnosis and personalized treatment of cystic fibrosis. J Rare Dis. 2024;13;3(1):28.","DOI":"10.1007\/s44162-024-00052-z"},{"issue":"9","key":"4145_CR29","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1136\/thorax-2023-220964","volume":"79","author":"S Cuyx","year":"2024","unstructured":"Cuyx S, Ramalho AS, Fieuws S, Corthout N, Proesmans M, Boon M, et al. Rectal organoid morphology analysis (ROMA) as a novel physiological assay for diagnostic classification in cystic fibrosis. Thorax. 2024;79(9):834\u201341.","journal-title":"Thorax"},{"issue":"10","key":"4145_CR30","doi-asserted-by":"publisher","first-page":"e1009100","DOI":"10.1371\/journal.pgen.1009100","volume":"16","author":"AT Joynt","year":"2020","unstructured":"Joynt AT, Evans TA, Pellicore MJ, Davis-Marcisak EF, Aksit MA, Eastman AC, et al. Evaluation of both exonic and intronic variants for effects on RNA splicing allows for accurate assessment of the effectiveness of precision therapies. PLoS Genet. 2020;16(10):e1009100.","journal-title":"PLoS Genet"},{"key":"4145_CR31","doi-asserted-by":"crossref","unstructured":"Morris-Rosendahl DJ, Edwards M, McDonnell MJ, John S, Alton EWFW, Davies JC et al. Whole-Gene Sequencing of CFTR Reveals a High Prevalence of the Intronic Variant c.3874-4522A\u2009>\u2009G in Cystic Fibrosis. Am J Respir Crit Care Med. 2020;201(11):1438\u201341.","DOI":"10.1164\/rccm.201908-1541LE"},{"issue":"3","key":"4145_CR32","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jcf.2021.10.011","volume":"21","author":"KS Raraigh","year":"2022","unstructured":"Raraigh KS, Aksit MA, Hetrick K, Pace RG, Ling H, O\u2019Neal W, et al. Complete CFTR gene sequencing in 5,058 individuals with cystic fibrosis informs variant-specific treatment. J Cyst Fibros Off J Eur Cyst Fibros Soc. 2022;21(3):463\u201370.","journal-title":"J Cyst Fibros Off J Eur Cyst Fibros Soc"},{"key":"4145_CR33","doi-asserted-by":"publisher","unstructured":"Zhang B, Zhang Y, Zhang Y, Liu X, Zhang R, Wang Z et al. Identified five variants in CFTR gene that alter RNA splicing by minigene assay. Front Genet [Internet]. 2025 Mar 20 [cited 2025 Sept 20];16. Available from: https:\/\/www.frontiersin.org\/journals\/genetics\/articles\/https:\/\/doi.org\/10.3389\/fgene.2025.1543623\/full","DOI":"10.3389\/fgene.2025.1543623\/full"},{"key":"4145_CR34","unstructured":"Sheridan MB, Aksit MA, Pagel K, Hetrick K, Shultz-Lutwyche H, Myers B et al. The clinical utility of sequencing the entirety of CFTR. J Cyst Fibros [Internet]. 2024 May 11 [cited 2024 July 5]; Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1569199324000626"},{"issue":"4","key":"4145_CR35","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1089\/ped.2015.0552","volume":"28","author":"L Guglani","year":"2015","unstructured":"Guglani L, Stabel D, Weiner DJ. False-Positive and False-Negative sweat tests: systematic review of the evidence. Pediatr Allergy Immunol Pulmonol. 2015;28(4):198\u2013211.","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"issue":"10","key":"4145_CR36","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1164\/rccm.200508-1330OC","volume":"173","author":"AM Cantin","year":"2006","unstructured":"Cantin AM, Hanrahan JW, Bilodeau G, Ellis L, Dupuis A, Liao J, et al. Cystic fibrosis transmembrane conductance regulator function is suppressed in cigarette smokers. Am J Respir Crit Care Med. 2006;173(10):1139\u201344.","journal-title":"Am J Respir Crit Care Med"},{"key":"4145_CR37","doi-asserted-by":"publisher","first-page":"107499","DOI":"10.1016\/j.rmed.2023.107499","volume":"221","author":"M Miravitlles","year":"2024","unstructured":"Miravitlles M, Criner GJ, Mall MA, Rowe SM, Vogelmeier CF, Hederer B, et al. Potential systemic effects of acquired CFTR dysfunction in COPD. Respir Med. 2024;221:107499.","journal-title":"Respir Med"},{"issue":"1","key":"4145_CR38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ccm.2015.11.003","volume":"37","author":"SV Raju","year":"2016","unstructured":"Raju SV, Solomon GM, Dransfield MT, Rowe SM. Acquired CFTR dysfunction in chronic bronchitis and other diseases of mucus clearance. Clin Chest Med. 2016;37(1):147\u201358.","journal-title":"Clin Chest Med"},{"issue":"11","key":"4145_CR39","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1164\/rccm.201304-0733OC","volume":"188","author":"SV Raju","year":"2013","unstructured":"Raju SV, Jackson PL, Courville CA, McNicholas CM, Sloane PA, Sabbatini G, et al. Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function. Am J Respir Crit Care Med. 2013;188(11):1321\u201330.","journal-title":"Am J Respir Crit Care Med"},{"key":"4145_CR40","doi-asserted-by":"crossref","unstructured":"Prenzel F, Ceglarek U, Adams I, Hammermann J, Issa U, Lohse G, et al. Audit of sweat chloride testing reveals analytical errors. Clin Chem Lab Med. 2021;27(8):1376\u201383.","DOI":"10.1515\/cclm-2020-1661"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04145-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-04145-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04145-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:38:24Z","timestamp":1767627504000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-025-04145-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4145"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-04145-w","relation":{},"ISSN":["1750-1172"],"issn-type":[{"type":"electronic","value":"1750-1172"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"6 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval for clinical research was obtained through the University of British Columbia (UBC-REB# H19-01506).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}